Sphingosylphosphorylcholine activates dendritic cells, stimulating the production of interleukin-12

Immunology

Volumn 121, Issue 3, 2007, Pages 328-336

  Ceballos, Ana ^a   Sabatté, Juan ^a   Nahmod, Karen ^b   Martínez, Diego ^b   Salamone, Gabriela ^b   Vermeulen, Mónica ^b   Maggini, Julián ^b   Salomón, Horacio ^a   Geffner, Jorge ^a,b,c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^c INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

Dendritic cells; Interleukin 12; Interleukin 18; Sphingosylphosphorylcholine

Indexed keywords

CD83 ANTIGEN; CD86 ANTIGEN; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 18; SPHINGOSYLPHOSPHORYLCHOLINE;

ANTIGEN EXPRESSION; ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL MATURATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOSTIMULATION; INFLAMMATION; MIXED LYMPHOCYTE REACTION; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH1 CELL;

ANTIGENS, CD; ANTIGENS, CD86; CALCIUM; CELLS, CULTURED; CHEMOTAXIS; DENDRITIC CELLS; ENDOCYTOSIS; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULINS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; LYMPHOCYTE CULTURE TEST, MIXED; MEMBRANE GLYCOPROTEINS; PHOSPHORYLCHOLINE; RECEPTORS, LYSOSPHINGOLIPID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHINGOSINE;

EID: 34249325139     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02578.x     Document Type: Article

References (53)

1. Spiegel S, Milstien S. Sphingolipid metabolites: members of a new class of lipid messengers. J Membr Biol 1995 146 : 225 37.
2. Meyer zu Heringdorf D, Himmel HM, Jakobs KH. Sphingosylphosphorylcholine - biological functions and mechanisms of action. Biochim Biophys Acta 2002 1582 : 178 89.
3. Desai NN, Spiegel S. Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines. Biochem Biophys Res Commun 1991 181 : 361 6.
4. Wakita H, Matsushita K, Nishimura K, Tokura Y, Furukawa F, Takigawa M. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. J Invest Dermatol 1998 110 : 253 8.
5. Bitar KN, Yamada H. Modulation of smooth muscle contraction by sphingosylphosphorylcholine. Am J Physiol 1995 269 : G370 7.
6. Thomas GD, Snetkov VA, Patel R, Leach RM, Aaronson PI, Ward JP. Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: activation of non-store-operated Ca2+ entry. Cardiovasc Res 2005 68 : 56 64.
7. Sun L, Xu L, Henry FA, Spiegel S, Nielsen TB. A new wound healing agent - sphingosylphosphorylcholine. J Invest Dermatol 1996 106 : 232 7.
8. Boguslawski G, Lyons D, Harvey KA, Kovala AT, English D. Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis. Biochem Biophys Res Commun 2000 272 : 603 9.
9. Kim KS, Ren J, Jiang Y et al. GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine. FASEB J 2005 19 : 819 21.
10. Lee T, Kim J, Sohn U. Sphingosylphosphorylcholine-induced contraction of feline ileal smooth muscle cells is mediated by Galphai3 protein and MAPK. Cell Signal 2002 14 : 989 97.
11. Shirao S, Kashiwagi S, Sato M et al. Sphingosylphosphorylcholine is a novel messenger for Rho-kinase-mediated Ca2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C. Circ Res 2002 91 : 112 9.
12. Chin TY, Chueh SH. Distinct Ca(2+) signaling mechanisms induced by ATP and sphingosylphosphorylcholine in porcine aortic smooth muscle cells. Br J Pharmacol 2000 129 : 1365 74.
13. Mogami K, Mizukami Y, Todoroki-Ikeda N et al. Sphingosylphosphorylcholine induces cytosolic Ca2+ elevation in endothelial cells in situ and causes endothelium-dependent relaxation through nitric oxide production in bovine coronary artery. FEBS Lett 1999 457 : 375 80.
14. Imokawa G, Takagi Y, Higuchi K, Kondo H, Yada Y. Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes. J Invest Dermatol 1999 112 : 91 6.
15. Suhr KB, Tsuboi R, Seo EY, Piao YJ, Lee JH, Park JK, Ogawa H. Sphingosylphosphorylcholine stimulates cellular fibronectin expression through upregulation of IL-6 in cultured human dermal fibroblasts. Arch Dermatol Res 2003 294 : 433 7.
16. Tokura Y, Wakita H, Seo N, Furukawa F, Nishimura K, Takigawa M. Modulation of T-lymphocyte proliferation by exogenous natural ceramides and sphingosylphosphorylcholine. J Invest Dermatol Symp Proc 1999 4 : 184 9.
17. Jin Y, Damaj BB, Maghazachi AA. Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. Eur J Immunol 2005 35 : 2699 708.
18. Van Koppen CJ, Meyer zu Heringdorf D, Zhang C, Laser KT, Jakobs KH. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils. Mol Pharmacol 1996 49 : 956 61.
19. Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002 20 : 621 67.
20. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003 21 : 685 711.
21. Ardavin C, Amigorena S, Reis e Sousa C. Dendritic cells: immunobiology and cancer immunotherapy. Immunity 2004 20 : 17 23.
22. Sporri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol 2005 6 : 163 70.
23. Reis E, Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006 6 : 476 83.
24. Murata Y, Ogata J, Higaki Y et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 1996 106 : 1242 9.
25. Chuluyan HE, Issekutz AC. VLA-4 integrin can mediate CD11/CD18- independent transendothelial migration of human monocytes. J Clin Invest 1993 92 : 2768 77.
26. Coligan JE, Kruibeek AM, Margulies DH, Shevach EM, Strober W. Morphological and biochemical assays of apoptosis. In : Coligan JE, ed. Current Protocols in Immunology. New York : Wiley, 1994 : 3.17.
27. Yee J, Christou NV. Neutrophil priming by lypopolysaccharide involves heterogeneity in calcium-mediated signal transduction. Studies using Fluo-3 and flow cytometry. J Immunol 1993 150 : 1988 97.
28. Kroeze WK, Sheffler DJ, Roth BL. G-protein-coupled receptors at a glance. J Cell Sci 2003 116 : 4867 9.
29. Kostenis E. Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for 'old' ligands. J Cell Biochem 2004 92 : 923 36.
30. Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine. G protein-coupled receptors and receptor-mediated signal transduction. Biochim Biophys Acta 2002 1582 : 81 8.
31. Xu Y, Zhu K, Hong G, Wu W, Baudhuin LM, Xiao Y, Damron DS. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat Cell Biol 2000 2 : 261 7.
32. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropynocitosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down regulation by cytokines and bacterial products. J Exp Med 1995 182 : 389 400.
33. Granucci F, Vizzardelli C, Virzi E, Rescigno M, Ricciardi-Castagnoli P. Transcriptional reprogramming of dendritic cells by differentiation stimuli. Eur J Immunol 2001 31 : 2539 46.
34. Yamada T, Okajima F, Ohwada S, Kondo Y. Growth inhibition of human pancreatic cancer cells by sphingosylphosphorylcholine and influence of culture conditions. Cell Mol Life Sci 1997 53 : 435 41.
35. Jeon ES, Kang YJ, Song HY, Woo JS, Jung JS, Kim YK, Kim JH. Role of MEK-ERK pathway in sphingosylphosphorylcholine-induced cell death in human adipose tissue-derived mesenchymal stem cells. Biochim Biophys Acta 2005 1734 : 25 33.
36. Ludwig MG, Vanek M, Guerini D et al. Proton-sensing G-protein-coupled receptors. Nature 2003 425 : 93 8.
37. Murakami N, Yokomizo T, Okuno T, Shimizu T. G2A is a proton sensing G-protein coupled receptor antagonized by lysophosphatidylcholine. J Biol Chem 2004 279 : 42484 91.
38. Wang JQ, Kon J, Mogi C et al. TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J Biol Chem 2004 279 : 45626 33.
39. Vermeulen M, Giordano M, Trevani AS et al. Acidosis improves uptake of antigens and MHC class I-restricted presentation by dendritic cells. J Immunol 2004 172 : 3196 204.
40. Kim KD, Lim HY, Lee HG et al. Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation. Biochem Biophys Res Comun 2005 338 : 1126 36.
41. Alewijnse AE, Michel MC. Sphingosine-1-phosphate and sphingosylphosphorylcholine: two of a kind? Br J Pharmacol 2006 147 : 347 8.
42. Chi H, Flavell RA. Cutting edge: regulation of T cell trafficking and primary immune responses by sphingosine 1-phosphate receptor 1. J Immunol 2005 174 : 2485 8.
43. Wei SH, Rosen H, Matheu MP et al. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol 2005 6 : 1228 35.
44. Idzko M, Panther E, Corinti S et al. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of TH2 immune responses. FASEB J 2002 16 : 625 7.
45. Czeloth N, Bernhardt G, Hofmann F, Genth H, Forster R. Sphingosine-1-phosphate mediates migration of mature dendritic cells. J Immunol 2005 175 : 2960 7.
46. Eigenbrod S, Derwand R, Jakl V, Endres S, Eigler A. Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells. Immunol Invest 2006 35 : 149 65.
47. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 2002 277 : 39436 42.
48. Clair T, Aoki J, Koh E et al. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res 2003 63 : 5446 53.
49. Coutant F, Perrin-Cocon L, Agaugue S, Delair T, Andre P, Lotteau V. Mature dendritic cell generation promoted by lysophosphatidylcholine. J Immunol 2002 169 : 1688 95.
50. Coutant F, Agaugue S, Perrin-Cocon L, Andre P, Lotteau V. Sensing environmental lipids by dendritic cell modulates its function. J Immunol 2004 172 : 54 60.
51. Panther E, Idzko M, Corinti S et al. The influence of lysophosphatidic acid on the functions of human dendritic cells. J Immunol 2002 169 : 4129 35.
52. Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA, Stracke ML. Autotaxin (NPP-2), a metastasis-enhancing mitogen, is an angiogenic factor. Cancer Res 2001 61 : 6938 44.
53. Koh E, Clair T, Woodhouse EC, Schiffmann E, Liotta L, Stracke M. Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and mitogenic activities. Cancer Res 2003 63 : 2042 5.